Ostomy prevalence and survival in elderly patients with stage III and IV rectal cancer
Corresponding Author
Bogdan Badic
CHRU Brest, Service de Chirurgie Viscérale, Brest, France
INSERM, UMR 1101, LaTIM, Brest, France
Correspondence
Bogdan Badic, MD, PhD, INSERM, UMR 1101, LaTIM 22 rue Camille Desmoulins, 29238 Brest, France.
Email: [email protected]
Search for more papers by this authorMaude Oguer
CHRU Brest, Service de Chirurgie Viscérale, Brest, France
INSERM, UMR 1101, LaTIM, Brest, France
Search for more papers by this authorMelanie Cariou
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
Search for more papers by this authorTiphaine Kermarrec
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
Search for more papers by this authorServane Bouzeloc
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
Search for more papers by this authorJean-Baptiste Nousbaum
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
CHRU Brest, Service d'Hépato-gastro-entérologie, Brest, France
Search for more papers by this authorMichel Robaszkiewicz
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
CHRU Brest, Service d'Hépato-gastro-entérologie, Brest, France
Search for more papers by this authorLucille Quénéhervé
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
CHRU Brest, Service d'Hépato-gastro-entérologie, Brest, France
Search for more papers by this authorCorresponding Author
Bogdan Badic
CHRU Brest, Service de Chirurgie Viscérale, Brest, France
INSERM, UMR 1101, LaTIM, Brest, France
Correspondence
Bogdan Badic, MD, PhD, INSERM, UMR 1101, LaTIM 22 rue Camille Desmoulins, 29238 Brest, France.
Email: [email protected]
Search for more papers by this authorMaude Oguer
CHRU Brest, Service de Chirurgie Viscérale, Brest, France
INSERM, UMR 1101, LaTIM, Brest, France
Search for more papers by this authorMelanie Cariou
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
Search for more papers by this authorTiphaine Kermarrec
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
Search for more papers by this authorServane Bouzeloc
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
Search for more papers by this authorJean-Baptiste Nousbaum
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
CHRU Brest, Service d'Hépato-gastro-entérologie, Brest, France
Search for more papers by this authorMichel Robaszkiewicz
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
CHRU Brest, Service d'Hépato-gastro-entérologie, Brest, France
Search for more papers by this authorLucille Quénéhervé
Registre des Cancers Digestifs du Finistère, Brest, France
EA7479 SPURBO, Université de Bretagne Occidentale, Brest, France
CHRU Brest, Service d'Hépato-gastro-entérologie, Brest, France
Search for more papers by this authorAbstract
Aim
Oncological strategies in the elderly population are often debated. The objective of this study was to investigate the survival rates and prevalence of ostomy in elderly patients operated on for stage III and IV rectal cancers.
Methods
This retrospective multicentric population-based study included 151 patients aged ≥75 years with stage III and IV rectal adenocarcinoma who underwent surgery between 2007 and 2014. Multivariable logistic regression was used to assess the impact of different prognostic factors.
Results
The median age of the patients was 81 years (range: 75–97 years) with 40 patients >85 years of age. Age was significantly correlated with overall survival (OS) in both stage III and IV cancers (P < 0.001). For patients ≥80 years the presence of comorbid conditions was associated with a lower chance of survival (P = 0.02). A digestive stoma was created in 67 (76.1%) patients with stage III cancer and 26 (29.54%) had a stoma reversal. A palliative derivative stoma was performed in half of patients with stage IV cancer. Adjuvant chemotherapy was independently associated with improved 5-year OS (P < 0.001).
Conclusions
Age, comorbidities and adjuvant chemotherapy were independent predictors for OS. Resection of rectal tumors in fit elderly patients should be promoted; however, patients should be aware of the high risk of stoma. Geriatr Gerontol Int 2021; 21: 670–675.
References
- 1Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017; 66: 683–691.
- 2Surveillance E, and End Results (SEER) Program. SEER*Stat Database: Incidence – SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973–2013 varying) – Linked To County Attributes – Total U.S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission. 2016.
- 3Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 2019; 14: 89–103.
- 4 Available from URL: CSA_Chp_4-4_Colon-and-Rectum.pdf.
- 5Marventano S, Grosso G, Mistretta A et al. Evaluation of four comorbidity indices and Charlson comorbidity index adjustment for colorectal cancer patients. Int J Colorectal Dis 2014; 29: 1159–1169.
- 6 Available from URL: charlson1994 (1) AVEC AGE.pdf
- 7Montroni I, Ugolini G, Saur NM et al. Personalized management of elderly patients with rectal cancer: expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer. Eur J Surg Oncol 2018; 44: 1685–1702.
- 8Fontani A, Martellucci J, Civitelli S, Tanzini G. Outcome of surgical treatment of colorectal cancer in the elderly. Updates Surg 2011; 63: 233–237.
- 9Kumar R, Jain K, Beeke C et al. A population-based study of metastatic colorectal cancer in individuals aged >/= 80 years: findings from the south Australian clinical registry for metastatic colorectal Cancer. Cancer 2013; 119: 722–728.
- 10Vacante M, Cristaldi E, Basile F, Borzi AM, Biondi A. Surgical approach and geriatric evaluation for elderly patients with colorectal cancer. Updates Surg 2019; 71: 411–417.
- 11 Finistere cancer registry database. http://registre-tumeurs-29.fr/accueil/. Accessed November 01, 2020.
- 12Barel F, Auffret A, Cariou M et al. High reproducibility is attainable in assessing histoprognostic parameters of pT1 colorectal cancer using routine histopathology slides and immunohistochemistry analyses. Pathology 2019; 51: 46–54.
- 13Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.
- 14De Marco MF, Janssen-Heijnen ML, van der Heijden LH, Coebergh JW. Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer 2000; 36: 95–99.
- 15Pule ML, Buckley E, Niyonsenga T, Roder D. The effects of comorbidity on colorectal cancer mortality in an Australian cancer population. Sci Rep 2019; 9: 8580.
- 16Gooiker GA, Dekker JW, Bastiaannet E et al. Risk factors for excess mortality in the first year after curative surgery for colorectal cancer. Ann Surg Oncol 2012; 19: 2428–2434.
- 17Simmonds PD, Best L, George S et al. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet 2000; 356: 968–974.
- 18Erichsen R, Horvath-Puho E, Iversen LH, Lash TL, Sorensen HT. Does comorbidity interact with colorectal cancer to increase mortality? A nationwide population-based cohort study. Br J Cancer 2013; 109: 2005–2013.
- 19Lemmens VE, Janssen-Heijnen ML, Verheij CD, Houterman S, van Driel OJR, Coebergh JW. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005; 92: 615–623.
- 20Rutten HJT, den Dulk M, Lemmens VEPP, van de Velde CJH, Marijnen CAM. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 2008; 9: 494–501.
- 21van der Valk MJM, Hilling DE, Bastiaannet E et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018; 391: 2537–2545.
- 22Holmgren K, Kverneng Hultberg D, Haapamäki MM, Matthiessen P, Rutegård J, Rutegård M. High stoma prevalence and stoma reversal complications following anterior resection for rectal cancer: a population-based multicentre study. Colorectal Dis 2017; 19: 1067–1075.
- 23Whitehead WE, Borrud L, Goode PS et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009; 137: 512–517, e1-2.
- 24Pachler J, Wille-Jørgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2003; 4: CD004323. https://doi.org/10.1002/14651858.CD004323.pub2.
- 25Tan WJ, Chew MH, Tan IB et al. Palliative surgical intervention in metastatic colorectal carcinoma: a prospective analysis of quality of life. Colorectal Dis 2016; 18: 357–363.
- 26Codd RJ, Evans MD, Davies M et al. Permanent stoma rates: a misleading marker of quality in rectal cancer surgery. Colorectal Dis 2014; 16: 276–280.
- 27van Hooft JE, Veld JV, Arnold D et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2020. Endoscopy 2020; 52: 389–407.
- 28Tyc-Szczepaniak D, Wyrwicz L, Kepka L et al. Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study. Ann Oncol 2013; 24: 2829–2834.
- 29De Felice F, Crocetti D, Maiuri V et al. Locally advanced rectal Cancer: treatment approach in elderly patients. Curr Treat Options Oncol 2020; 21: 1.
- 30Francois E, Azria D, Gourgou-Bourgade S et al. Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy. Radiother Oncol 2014; 110: 144–149.
- 31Ahn DH, Wu C, Wei L et al. The efficacy of adjuvant chemotherapy in patients with stage II/III resected rectal Cancer treated with Neoadjuvant Chemoradiation therapy. Am J Clin Oncol 2017; 40: 531–534.
- 32Dekker JW, van den Broek CB, Bastiaannet E, van de Geest LG, Tollenaar RA, Liefers GJ. Importance of the first postoperative year in the prognosis of elderly colorectal cancer patients. Ann Surg Oncol 2011; 18: 1533–1539.
- 33Decoster L, Van Puyvelde K, Mohile S et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger. Ann Oncol 2015; 26: 288–300.